View in EDS HTML Full Text PDF Full Text

Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant.

Saved in:
Bibliographic Details
Title: Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant.
Authors: Chang CC; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Liu YN; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Xu Z; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Vasilescu ER; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Li P; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Ho EK; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Li M; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Husain SA; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, NY, United States.; Department of Epidemiology, The Columbia University Renal Epidemiology Group, Columbia University, New York, NY, United States., Bhagat G; Department of Pathology and Cell Biology, Division of Hematopathology, Columbia University Irving Medical Center, New York, NY, United States., Mohan S; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, NY, United States.; Department of Epidemiology, The Columbia University Renal Epidemiology Group, Columbia University, New York, NY, United States., Vlad G; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Suciu-Foca N; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.
Source: Frontiers in immunology [Front Immunol] 2025 Oct 06; Vol. 16, pp. 1664371. Date of Electronic Publication: 2025 Oct 06 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41122178
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chang+CC%22">Chang CC</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Liu+YN%22">Liu YN</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Xu+Z%22">Xu Z</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Vasilescu+ER%22">Vasilescu ER</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Li+P%22">Li P</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Ho+EK%22">Ho EK</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Husain+SA%22">Husain SA</searchLink>; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, NY, United States.; Department of Epidemiology, The Columbia University Renal Epidemiology Group, Columbia University, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Bhagat+G%22">Bhagat G</searchLink>; Department of Pathology and Cell Biology, Division of Hematopathology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Mohan+S%22">Mohan S</searchLink>; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, NY, United States.; Department of Epidemiology, The Columbia University Renal Epidemiology Group, Columbia University, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Vlad+G%22">Vlad G</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Suciu-Foca+N%22">Suciu-Foca N</searchLink>; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Oct 06; Vol. 16, pp. 1664371. <i>Date of Electronic Publication: </i>2025 Oct 06 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41122178
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1664371
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1664371
    Titles:
      – TitleFull: Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chang CC
      – PersonEntity:
          Name:
            NameFull: Liu YN
      – PersonEntity:
          Name:
            NameFull: Xu Z
      – PersonEntity:
          Name:
            NameFull: Vasilescu ER
      – PersonEntity:
          Name:
            NameFull: Li P
      – PersonEntity:
          Name:
            NameFull: Ho EK
      – PersonEntity:
          Name:
            NameFull: Li M
      – PersonEntity:
          Name:
            NameFull: Husain SA
      – PersonEntity:
          Name:
            NameFull: Bhagat G
      – PersonEntity:
          Name:
            NameFull: Mohan S
      – PersonEntity:
          Name:
            NameFull: Vlad G
      – PersonEntity:
          Name:
            NameFull: Suciu-Foca N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 10
              Text: 2025 Oct 06
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1